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Introduction. Hydrogen is the most abundant element in
the body. When bound to carbon, it usually will not dis-
sociate, but it often does so when bound to oxygen, nitrogen
or sulfur. Hence, acid-base groups are ubiquitous in bio-
chemistry. Furthermore, it must be appreciated that water
provides the environment in which most biochemical
reactions occur and water is itself both an acid and a base
by virtue of the fact that it can dissociate to a very slight
degree as follows:
H2O+H2O±H3O+OH
Therefore, in aqueous solutions hydrated protons (hydro-
nium ions) and hydroxyl ions are always present.
Despite the abundance of hydrogen and the ubiquity of
acid-base reactions, the concentration (or, more properly,
the chemical activity) of free hydrogen or hydronium ions
is very low in most biological fluids. This is in part because
these ions are constantly being consumed in a great variety
of metabolic reactions; but the main reason is that there
exist in all body fluids relatively large concentrations of
buffer substances with basic groups that have a high affinity
for protons. It is the presence of these buffers in cells that
permits a very rapid metabolic turnover of protons to take
place at concentrations as low as 10—6 or l0 M.
Although the concentration of protons is quite low, these
ions are highly reactive and their chemical potential (as
indicated by the pH) has a pervasive and often critical
influence on a wide variety of biochemical systems. Most
of the biological effects of pH are due primarily to changes
in the ionization of molecules resulting from protonation
or deprotonation. By affecting the charge on proteins
(enzymes) and other critical reactive groups, pH influences
the rates of metabolic reactions, the behavior of biological
membranes and membrane transport systems, the binding
of molecules, the actions and distribution of drugs and so
forth. The mechanisms that serve normally to regulate pH,
as well as the whole spectrum of functional disturbances
that result from the changes in body fluid pH produced by
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stress or disease, will probably all find their ultimate expla-
nations in these terms.
As an example of the ways in which metabolic pathways
can be critically affected by pH, I have chosen to discuss in
detail the effects of acid-base changes on glycolysis. In
order to put these phenomena in perspective, it will also be
necessary to describe more briefly what is known about the
effects of pH on certain related processes such as the citric
acid cycle, oxidative reactions, gluconeogenesis and the
hexose monophosphate shunt. The principles illustrated in
this discussion will undoubtedly prove to be applicable to
other areas of metabolism as we continue to learn more
about the metabolic consequences of acid-base disorders.
Glycolysis and pH
Ever since the original observations of MacLeod and
Hoover in 1916 [1], numerous investigators have confirmed
that alkalosis, whether metabolic or respiratory, increases
aerobic production of lactate. This is true in a great variety
of experimental systems, and under in vitro as well as in vivo
conditions (e.g., [2—7]). The striking degree to which
aerobic glycolysis is dependent upon pH is illustrated by
some unpublished observations made in my laboratory, in
collaboration with Miss I-I. P. Connors. The data are sum-
marized in Table 1. In these experiments strips of rat
diaphragm muscle were incubated at 37°C in Krebs-Ringer
Table 1. Effect of pH on aerobic and anaerobic glycolysis in rat
diaphragm muscle in vitro
pH
Lactate production
nanomoles/lO mm/mg protein
Aerobic Anaerobic
5.7 5 12
6.1 13 53
6.6 18 49
7.1 28 96
7.4 43 167
7.8 83 284
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bicarbonate buffer, which contained 5 mvs glucose as sub-
strate. The medium was gassed with 5 % CO2 and 95% N2
or 02. The pH was varied by substituting chloride for
bicarbonate, and lactate production was measured over
ten minute periods.
The Table shows that lactate production in oxygen increa-
sed approximately 15-fold as the pH of the medium was
increased from 5.7 to 7.8. A similar effect occurred when
pH was varied over the same range by changing the Pco2
instead of the bicarbonate concentration in the medium.
The explanation of this phenomenon appears to lie
primarily, though not exclusively, in the remarkable sensi-
tivity of the phosphofructokinase reaction to ambient pH.
This reaction involves the phosphorylation of fructose
6-P by ATP, as follows:
Fructose-6-P+ATP—* Fructose 1, 6-P2+ADP.
Phosphofructokinase (PFK) is one of the eleven enzymes
involved in the sequential conversion of glucose to lactate
(Embden-Meyerhof pathway). To help the reader follow
the subsequent discussion, the sequential enzymatic steps
in glycolysis, together with their substrates and products,
are summarized in Table 2.
Inasmuch as the PFK reaction is one of the only three
essentially irreversible reactions in the Embden-Meyerhof
pathway, and the first such reaction that commits substrate
Table 2. The glycolytic sequence
Reaction (enzyme) Substrate Product
1. Hexokinasea, b Glucose Glucose-6-P
2. Phosphoglucose
isomerase
Glucose-6-P Fructose-6-P
3. Phosphofructo-
kinase° b
Fructose-6-P Fructose-l,6-P,
4. Aldolase Fructose-l,6-P2 Glyceraldehyde-3-P
and Dihydroxy-
acetone-P
5. Isomerase Dihydroxy-
acetone-P
Glyceraldehyde-3-P
6. Glyceraldehyde-
3-P-dehydro-
genase b
Glyceraldehyde-3-P I ,3-P2-Glyceric
acid
7. Phosphoglyceric
kinase
l,3-P2-Glyceric
acid
3-P-Glyceric acid
8. Phospho-
glyceromutase
3-P-Glyceric Acid 2-P Glyceric acid
9. Enolase 2-P-Glyceric Acid Phospho-enol-
pyruvic acid
10. Pyruvic
kinasea, h
Phospho-enol-
pyruvic acid
Pyruvic acid
11. Lactic dehydro- Pyruvic acid Lactic acid
genase
to the formation of pyruvate, variations in the activity of the
PFK enzyme might be expected to play a major role in the
regulation of the overall rate of glycolysis. This, in fact,
has proved to be the case, for there is now considerable
evidence that the PFK enzyme, an allosteric protein of
great complexity that is influenced by a wide variety of
regulatory factors, is one of the important points, if not
the most important point, in the biological control of gly-
colysis [81. However, hexokinase is the first irreversible step
in the entire Embden-Meyerhof sequence leading from
glucose to pyruvate and lactate, and no change in the
activity of PFK could affect the overall rate of glycolysis
unless it fed back to the first irreversible step and enhanced
the hexokinase reaction. This requirement is met through
the mediation of glucose-6-P, which is a competitive inhib-
itor of the "low Km" type of hexokinase that is found
in glycolytic tissues. Increased PFK activity reduces the
concentration of glucose-6-P, and thereby facilitates hexo-
kinase [8].
That the PFK reaction is critical in the enhancement of
glycolysis by a rise in pH can be shown in several ways.
Perhaps the most convincing evidence is provided by the
use of so-called "cross-over" experiments. In this type of
study, the concentration of the substrates in the Embden-
Meyerhof pathway are measured at two different pH values.
The conversion of glucose to lactate is more rapid in the
relatively alkaline medium, so the concentration of glucose
would be expected to be lower, and that of lactate higher,
than in the acid medium. Beyond this, however, one finds
that the concentration of each of the substrates that are
before the PFK reaction in the Embden-Meyerhof pathway
is lowered in the alkaline medium, whereas all of the sub-
strates that follow the PFK reaction are increased. Results
of an experiment of this type are illustrated in Fig. 1, which
is taken from a study carried out a few years ago in collabo-
ration with Halperin, Connors and Karnovsky [9J. The
system under study was a 15 to 20% suspension of guinea
pig leukocytes in the Krebs-Ringer phosphate medium
containing 5 m glucose, which was incubated at 370 C in
air for 30 minutes. Substrate concentrations at pH 6,7 are
a
150- <-" -
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Glc-6-P Fru-6-P Fru-l,6-P2 Triose Lactate
Fig. I. The effect of a rise in pH upon the production of lactate
and the concentrations of certain intermediates in the Embden-
a Completely irreversible reactions. Meyerhof pathway in respiring guinea pig leukocytes. See text
b Far from equilibrium, in Vito. fordetails. Reproduced, by permission, from reference [9].
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plotted in the figure as "100%", and the concentrations of
intermediates shown on this scale are those at pH 7.6. As
shown in the figure, the concentrations of glucose-6-P and
fructose-6-P (F6P) are lower in the alkaline medium than
in the acid medium, but the concentrations of fructose-I,6-
P2 (FDP), trioses (glyceraldehyde-3-P and dihydroxyace-
tone-P) and lactate are higher. There is, in other words, a
"cross-over" between fructose-6-P and FDP. Although
this kind of evidence can sometimes be misleading [8],
the conditions of the present experiment were such as to
permit the conclusion that the PFK reaction was specif i-
cally enhanced by a rise in pH [9].
It should be noted in Fig. I that there appeared to be at
least one other reaction, some place beyond the formation
of the trioses, that was important in the acceleration of
lactate formation. This conclusion is suggested by the fact
that the concentration of triose in the alkaline medium is
not significantly increased above control. Further evidence
for the existence of a second locus for the pH effect was
provided by additional experiments in which various inter-
mediates in the Embden-Meyerhof pathway were used as
a substrate instead of glucose. In order to insure access
of these phosphorylated compounds to the intracellular
enzymes, an homogenate preparation of guinea pig leuko-
cytes was employed [9]. Experiments of this type indicated
that a rise in pH not only accelerated the formation of
lactate from glucose, glucose-6-P and fructose-6-P, but also
from FDP. "Cross-over" experiments with the latter com-
pound as substrate suggested that the second locus of pH
effect is either at the glyceraldehyde-3-P dehydrogenase or
the phosphoglyceric kinase reaction. The dehydrogenase
is a more likely control site than is the kinase, because the
former reaction, like the PFK reaction, appears to be
operating in vivo far from equilibrium and therefore can be
considered normally a rate-limiting step in the Embden-
Meyerhof sequence [8] (Table 2). How much the dehydro-
genase reaction contributes to the total effect of pH on
glycolysis, when compared to the PFK reaction, cannot be
determined from the evidence at hand.
Other workers, studying the effects of pH on glycolysis
in human red blood cells in vitro [10] and in the isolated
perfused rat heart [II], have also employed the "cross-
over" technique (using only glucose as substrate) and have
concluded that PFK is the primary site of regulation.
However, it is perhaps important that in one of these
studies [11] glyceraldehyde-3-P was not significantly in-
creased in the alkaline medium, despite very large incre-
ments in pyruvate, thus suggesting again that a second
reaction, at or beyond the glyceraldehyde-3-P dehydro-
genase step, is also enhanced by a rise in pH.
Before leaving this subject, it should be pointed out that
one interpretation of the "cross-over" between F6P and
FDP could be that the reaction that reverses the formation
of FDP,
fructose- 1,6-P2 fructose-6-P + P.
is inhibited by alkalosis and enhanced by acidosis. The
enzyme that catalyzes this hydrolytic step, diphosphofruc-
tose phosphatase, is a key factor in the gluconeogenic
pathway in liver and kidney, and reciprocal variations in
kinase and phosphatase reactions are believed to be impro-
tant in the control of what would otherwise be a "futile
cycle" between F6P and FDP [8]. However, diphospho-
fructose phosphatase activity is negligibly small in tissues
that are incapable of gluconeogenesis, such as leukocytes [9]
and skeletal and cardiac muscle [8], although the glycolytic
rate in these tissues is nevertheless highly responsive to pH.
It is obvious, therefore, that the "cross-over" between F6P
and FDP that has been found with pH change in leukocytes
[9] and heart muscle [11] must be due primarily to changes
in the rate of the PFK reaction.
Available information on the pH-sensitivity of PFK is at
least consistent with the idea that this enzyme plays a key
role in the pH control of glycolysis. Virtually all enzymes
have well-defined pH optima, and several of the enzymes
listed in Table 2 show increasing activity with pH, over the
physiological range. Although it is, therefore, impossible
to identify PFK as the most important control point simply
by examining the pH-activity curves of all the glycolytic
enzymes, it is, nevertheless, significant that the kinetic para-
meters for PFK appear to be extraordinarily sensitive to
pH.
In studies using purified enzyme from sheep heart [12],
as well as those with frog and mouse muscle extracts [13],
PFK has been found to exhibit a steep sigmoidal pH-
activity curve in the physiological range. Recent work with
partially purified preparations of PFK from human skeletal
muscle and erythrocytes indicates a similar sensitivity to
relatively small change in pH [14].' It has also been shown
that the pH sensitivity of PFK in a primarily gluconeogenic
tissue like liver is the same as that of PFK in muscle [16].
An illustration of the remarkable effect of small changes
in pH on the behavior of PFK is presented in Table 3,
which summarizes data recently published in a study of the
kinetics of purified enzyme from rabbit skeletal muscle [17].
As shown in the Table, an increase of only 0.35 pH units
increased the maximal velocity of the enzyme from 75 to
110 units/mg and decreased the fructose-6-P concentration
necessary for half-maximal velocity from 0.30 mM to
0.079 mrvt. Of further interest is the change in the Hill inter-
action coefficient from 6.8 to 8.5 at pH 7.0, to 1.9 at pH 7.35.
All these observations were carried out in the presence of
2 mivi ATP. The possible explanation of these effects is
discussed below.
The mechanism of the pH effect on PFK. It is not yet
possible to provide a definitive explanation of the molecular
In view of the suggestion made above that glyceraldehyde-3-P
dehydrogenase may also be a key to the pH control of glyco-
lysis, it is interesting that this enzyme also displays a pH
optimum in the alkaline range [15}; a recent study reports a
steep activation curve that rises from virtually zero activity
at pH 6.0 to a maximum at approximately pH 8.5 [751.
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Table 3. Influence of pH on the kinetics of purified skeletal
muscle phosphofructokinase
pH
Fructose-6-P
for half-max.
velocity
mM
Vmax
units/mg
Hill
Interaction
Coeff.
7.0 0.30 75 6.5—8.5
7.35 0.079 110 1.9
Data from (17). All assays performed at 26°C, with 2mM ATP
and a final PFK concentration of 0.3 ig/ml. See (17) for further
details.
phenomena responsible for the striking effect of pH on
PFK, but recent studies have helped to clarify the problem.
PFK is a complex protein with allosteric binding sites
that are distinct from the catalytic sites for the two sub-
strates, fructose-6-P and ATP [18, 19]. Citrate and high
concentrations of ATP inhibit the activity of PFK and
raise its Km for fructose-6-P, apparently by binding to
allosteric sites and thereby reducing the binding of fructose-
6-P to the catalytic site [20, 21]. This inhibition is reversed
by a large variety of cofactors, including ADP, AMP,
cyclic 3',5'-AMP, inorganic phosphate and NH [12, 14,
18—23]. The deinhibiting actions of these modifiers may
depend upon their ability to block the binding of ATP and
citrate to the allosteric sites and also upon their capacity
directly to interfere with the binding of ATP and F6P to the
catalytic sites on the enzyme [20].
One possible mechanism through which changes in pH
might influence the enzyme would be through pH-induced
changes in the concentrations of some of the regulatory
cofactors. This possibility was tested and ruled out by the
results of experiments with guinea pig leukocytes [9], in
which it was shown that the effects of pH on glycolysis
occurred independently of spontaneous changes in the con-
centration of inorganic phosphate and the adenine nucleo-
tides. Furthermore, although the concentration of ATP
influences the shape and position of the pH-activity curve
for PFK [24], the experiments with leukocytes showed that
pH control continued to be demonstrable over a wide range
of experimentally-induced concentrations of ATP, and of
other adenine nucleotides and inorganic phosphate [9].
The possibility that variations in citrate concentration may
be an essential part of the mechanism of control seems to
be ruled out by the fact that the effect of pH can easily be
demonstrated in pure glycolytic systems, such as red blood
cells, in which no citrate is present [6]. Moreover, in cells
that do have mitochondria, the concentration of citrate
usually rises in alkalosis, a change that would be expected
to inhibit, rather than enhance, the action of PFK. The
significance of this rise in citrate will be discussed in more
detail below.
On the other hand it is clear that pH has an important
influence on the inhibiting action of both ATP and citrate,
because several studies have indicated that this inhibition is
demonstrable only in relatively acid media [19, 22]. Further-
more, it has been shown that the inhibiting effect of ATP on
frog skeletal muscle PFK is critically dependent on pH over
a relatively narrow range from 6.2 to 7.2 [25]. Experiments
carried out with crystalline sheep heart PFK offer a prob-
able explanation of this phenomenon, for they demonstrate
that neither ATP nor citrate can bind to the allosteric sites
on PFK in an alkaline medium [20], The striking reduction
in the Hill interaction coefficient shown in Table 3, when
pH is increased from 7.0 to 7.35, can thus be explained by
inhibition of ATP binding to the allosteric sites and a
consequent reduction in the interactive behavior of the
enzyme. It seems likely, therefore, that at least one explana-
tion of the sensitivity of PFK to pH is an effect of pH on
the charge or conformation of the allosteric sites on the pro-
tein, which changes the affinity of these sites for ATP and
citrate and thereby influences catalytic activity.
Another mechanism by which pH might change the
activity of PFK is suggested by the observation that the
molecular weight of the purified enzyme prepared at
pH 6.5 is approximately 160,000, whereas that prepared at
pH 8.0 is greater than 300,000 [19]. It has been suggested
that PFK is a dimer, which is in equilibrium with two proto-
mers. The dimer is the more active form of the enzyme, and
the association-dissociation equilibrium between the two
forms is influenced by pH (and by ATP concentration) [19].
According to this hypothesis, pH is viewed as controlling
the tertiary or quaternary structure of the enzyme and there-
by modifying its kinetic properties, presumably by altering
the number and accessibility of active sites per unit of
protein.
Thus, although much remains to be learned about the
effects of pH on the PFK reaction, the weight of evidence
suggests that changes in hydrogen ion activity exert their
major influence directly upon the enzyme protein, rather
than upon the numerous regulatory molecules that nor-
mally control the kinetic behavior of PFK. The complex
structure of the enzyme would appear to offer many possible
sites where alterations in net charge, produced by protona-
tion or deprotonation, might affect the conformation of the
molecule or its state of aggregation, and thereby influence
its catalytic action. A more detailed understanding of these
phenomena must await the final elucidation of the structure
of the PFK protein.
The relation between the Pasteur effect and the pH
control of glycolysis. The Pasteur effect (an increase in the
rate of glycolysis caused by a transition from aerobic to
anaerobic conditions) is one of the best known examples
of metabolic control. In mammalian organisms and in
isolated tissues and organs, the increase in glucose con-
sumption and lactate production that characterizes hypoxic
states is a familiar phenomenon. Its importance for survival
has long been recognized, for when relative or absolute
oxygen deficiency interferes with oxidative phosphorylation,
ATP must be supplied through enhancement of glycolytic
activity.
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Most recent work on this problem points once again to
PFK as the primary point of control [8]. Thus, for example,
in studies on mouse brain in situ [26], perfused rat heart [27]
and rat kidney cortex slices [281, it was found that acute
anoxia greatly accelerated conversion of glucose to lactate
and produced a "cross-over" between F6P and FDP. In
the rat heart experiments [27], calculation of the mass action
ratio of products to reactants showed that four glycolytic
reactions (hexokinase, PFK, glyceraldehyde dehydrogenase
and pyruvic kinase) were always significantly displaced
from thermodynamic equilibrium. Of these reactions, only
PFK appeared to be activated by the transition from
aerobiasis to anaerobiasis and moved closer to equilibrium.
With anoxia there are important changes in the concen-
trations of many of the cofactors that regulate PFK activity.
Within seconds after the aerobic-anaerobic transition, sig-
nificant reductions in ATP concentration and significant
increases in ADP, AMP and P can be observed [26—28].
During this same period there are moderate reductions in
tissue citrate levels [29]. As explained above, the net result
of all these changes in regulatory factors would be to
enhance the catalytic activity of PFK. Therefore, the pre-
vailing view at present is that the Pasteur effect is due to
allosteric modulation of PFK activity, mediated through
change in the concentrations of the cofactors that are
dependent upon oxidative phosphorylation [8].
Thus, both pH and anoxia appear to exert a major part
of their control of glycolysis at the same point in the
Embden-Meyerhof pathway, but the mechanisms in each
case are quite different. Whereas changes in pH directly
modify the PFK molecule and thereby alter the affinity of
the enzyme for its substrates and modifiers, the aerobic-
anaerobic transition changes the concentrations of cofactors
which, in turn, exert an allosteric affect on the enzyme.
This difference in mechanism of control predicts that
each of these factors, p1-I change and level of oxygenation,
should exert independent control of glycolysis. These inde-
pendent effects should be demonstrable regardless of
whether they are acting in concert or in opposition. A
partial confirmation of this prediction was provided by
earlier work with rat diphragm muscle [7], which showed
that the pH effect was still apparent when the diaphragm
muscle was incubated anaerobically. A recent and more
detailed study in intact leukocytes [9] demonstrated that a
given change in pH produced approximately the same per-
centile change in glycolysis under aerobic as well as anaero-
bic conditions. Similarly, the transition between anaerobia-
sis and aerobiasis caused approximately the same percen-
tile change in glycolysis at low pH as it did at high pH [9].
The unpublished data on intact rat diaphragm muscle
shown in Table 1 demonstrate the same phenomenon. Thus
a rise in pH from 6.1 to 7.8 resulted in an approximately
six-fold rise in lactate production under aerobic as well as
anaerobic conditions, and at each pH level from 6.1 to
7.8 the transition from aerobiasis to anaerobiasis caused
a three to four-fold increase in glycolysis. The data in
Table I also show that anaerobic as well as aerobic glycol-
ysis is almost totally inhibited when the medium pH faIls
below 6.0. Other studies in my laboratory have shown that
this inhibition is at least partially reversible.
Effects of pH on energy-producing pathways beyond
pyruvate. The description of the glycolytic sequence sum-
marized in Table 2 makes it appear as if there were a single
straight-line metabolic pathway from glucose to lactate, but
of course this is not the case. There are in fact several
branching points at which intermediates in the Embden-
Meyerhof sequence can be diverted in other directions,
thereby increasing the complexity of any analysis of the
control of glycolysis. From this standpoint, the most import-
ant of these branching points occurs at the level of pyruvate.
In most mammalian cells capable of oxidative phosphory-
lation pyruvate is the substrate for at least two major
reactions other than lactic dehydrogenase: 1) intramiro-
chondrial oxidative decarboxylation to form acetyl CoA.
This is an essentially irreversible reaction. The major
aerobic fate of acetyl CoA is then condensation with
oxaloacetate to form citrate (via the citrate synthase reac-
tion), which is the initial step in oxidation via the citric acid
cycle. 2) intramitochondrial carboxylation to form oxalo-
acetate (pyruvic acid carboxylase reaction). This key reac-
tion is also irreversible. It serves to sustain the supply of
oxaloacetate for the citric acid cycle. It also is the first step
in the conversion of pyruvate to phospho-enol-pyruvate,
which process bypasses the irreversible pyruvic kinase reac-
tion (Table 2) and thus allows for the reversal of glycolysis
in gluconeogenic tissues like liver and renal cortex. The
subsequent conversion of oxaloacetate to phospho-enol-
pyruvate via the phospho-enol-pyruvate carboxykinase
(PEPCK) reaction is another important gluconeogenic reac-
tion that could potentially affect pyruvate concentration in
such tissues.
Thus, the concentration of pyruvate in the cytoplasm
which is in equilibrium with lactate via the lactic dehydro-
genase reaction is determined not only by the rate of forma-
tion of pyruvic acid through the Embden-Meyerhof path-
way but also by the rate at which pyruvate is utilized in the
citric acid cycle (starting with the decarboxylase reaction)
and by the rate at which it is utilized in the pyruvic car-
boxylase and PEPCK pathway that leads to gluconeogene-
sis. Other metabolic fates of pyruvic acid, such as utili-
zation for synthesis of lipid or transamination to form
alanine are probably of minor importance in the net dispo-
sition of pyruvate under most circumstances. There is
relatively little detailed information about the effects of
pH on the major pathways of pyruvate utilization, but the
available evidence seems to suggest that alkalosis not only
enhances the production of pyruvate but also inhibits the
utilization of pyruvate in the oxidative and gluconeogenic
pathways.
Oxidation. Studies of the effects of pH on oxygen con-
sumption in the intact organism are complicated by acid-
base effects on circulatory function [30], but experiments
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with isolated organs, whole tissues or mitochondria show
that pH has little or no influence on oxygen consumption
in the steady state (e.g., [7, 31—33]). On the other hand,
there is evidence to suggest that alkalosis in some way blocks
mitochondrial oxidation and inhibits the rate at which the
citric acid cycle turns over. Increasing the pH of the medium
reduces the production of '4C02 from acetate-1-'4C in liver
slices [34, 35]. Respiring pigeon heart mitochondria are
very sensitive to pH; small increases in alkalinity within
the range of pH 6.5 to 7.5 cause a marked reduction in the
state of oxidation and an increase in NADH concentration
[36]. Conversely, addition of acid transiently increases
oxygen consumption and reduces NADH concentration
[36]. Measurements of NADH and NAD in whole tissues
have also suggested an impairment of oxidation with rising
pH. In the kidneys of acidotic rats the ratio of NADH to
NAD has been found to be decreased [37, 38]. Dr. M.
L. Halperin and I have measured the NADH/NAD ratio
in the liver and renal cortex of dogs approximately 30 min-
utes after they were made acutely acidotic (arteriar pH:
6.9 to 7.1) or alkalotic (arterial pH: 7.6 to 78) by means of
varying the CO2 tension of plasma bicarbonate level. In
acidotic dogs we found that the mean ratio was reduced
from normal by about a third in liver and kidney; with
alkalosis, the ratio was increased above normal by about
24% in liver and 83% in kidney (unpublished obser-
vations).2 In the new steady state that follows the acute
effects of pH change on the redox condition of the tissues,
the rate of ATP formation must rapidly return to control
levels, because we found no significant change in ATP
levels in either organ.
The molecular mechanism of this effect of pH on the
redox state of cells is not known, but it has been demonstra-
ted that the oxidation-reduction potential of cytochrome
c decreases sharply with increasing pH [39] and there is
evidence to suggest that this may be due to a pH-dependent
change in the conformation of the cytochrome protein
which affects its ability to participate in oxidation-reduction
reactions [40]. A recent report on the pH-dependence of the
nuclear magnetic resonance spectra of cytochrome c [41]
is compatible with this proposed mechanism, which would
be analagous to the mechanisms thought to be responsible
for the pH effect on PFK. That pH may influence the
redox state of other components of the electron transport
2 Chemical measurement of total pyridine nucleotides in tissues
is probably not a reliable method for determing NADH/NAD
ratios, for it does not distinguish between free and bound
nucleotides and does not deal with the problem of compart-
mentation of nucleotides between cytoplasm and mitochondria
1691. A more satisfactory method is to measure the ratio of
the concentrations of the oxidized and reduced metabolites of
a suitable NAD-linked dehydrogenase system which is at or
very near equilibrium in one or the other cell compartment
[69—7!]. The cytoplasmic lactic dehydrogenase system can be
applied in this way and the results seem to support the view
that alkalosis lowers the state of oxidation of the NAD couple
in cytoplasm. This subject is discussed in a later section.
chain is suggested by a recent study of the effects of pH on
the absorption spectrum of cytochrome b in rat liver
mitochondria [42].
Citric acid cycle. Further evidence for a block in the
pathway leading to oxidation of pyruvic acid is provided
by studies of the effect of pH on the concentration and
metabolism of citric acid cycle intermediates, particularly
citric acid itself. it is generally recognized that the concen-
tration of citrate in various tissues is reduced in acidosis and
increased in alkalosis (e.g., [43—46]). How much of this
effect is explained by control of the oxidation of citrate
through changes in intracellular or intramitochondrial pH,
or bicarbonate [45—48], and how much by an increased
rate of formation of citrate via the citrate synthase reaction
[43] is not yet clear. Under in vitro conditions, partially
purified citrate synthase from beef heart and beef liver
demonstrates a steep rise in activity with pH in the range
from 6.5 to 7.5 [49]. However, physiological interpretation
of this fact cannot be made until there is more information
about the applicability of the conditions used in the in vitro
enzyme assay to higher levels of biological organization.
The renal tissue concentrations of some of the other
citric acid cycle intermediates that can be measured have
been reported to be either increased in acute and chronic
alkalosis, or decreased in acute and chronic acidosis [50—53].
A more complete analysis of the acute effects of pH change
on the concentrations of citric acid cycle intermediates in
the liver as well as the rena! cortex of the dog is given in
Table 4. The data are taken from unpublished experiments,
carried out in collaboration with Dr. M. L. Halperin, in
which normal dogs were made acutely acidotic (arterial
pH: 6.9 to 7.1) or alkalotic (arterial pH: 7.6 to 7.8) by
rapid infusion of HG! or NaHCO3 or by induced variations
in P02. Tissue samples were taken before, and approxi-
mately 30 minutes after, acidosis or alkalosis had been
induced. In order to correct for variations in absolute
values between animals, and to facilitate comparison, the
data were normalized by expressing the concentrations
measured in each animal during acidosis and alkalosis as a
percent of the control value in that animal. The values in
the Table are the means of these percentages (±SEM), as
calculated from duplicate analyses of tissues taken from
five to fifteen dogs.
It is apparent from the data in Table 4 that the concen-
trations of virtually all the citric acid cycle intermediates
were significantly higher in alkalosis than in acidosis, in
both the liver and the kidney cortex. The only exception to
this rule was the concentration of malate in the kidney,
which inexplicably seemed to increase in acidosis as well
as alka!osis. Lactate and pyruvate, also shown in Table 4,
were significantly higher in alkalosis, as expected. ATP
levels, not shown in the Table 4, were unchanged. Of par-
ticular interest was an apparent difference between liver and
kidney in their response to alkalosis. In the liver alkalosis
caused little or no increase beyond normal in the concen-
trations of any of the citric acid cycle intermediates, other
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Table 4. Effects of acute acidosis and alkalosis on tissue concentrations of lactate, pyruvate and citric acid cycle intermediates
in dog liver and renal cortexa, b
Citrate Isocitrate cC-Ketoglutarate Fumarate Malate Oxaloacetate Pyruvate Lactate
Liver
Acidosis 74.8± 7.9 66.1±5.6 64.7±6.4 79± 6* 68.8± 5.0 113 3.5 109 7.6k
Alkalosis 101 136 131 ll3±l6 90.2± 8.8 215.3±37.6 162.4±31* 173.5±20.3
Kidney
Acidosis 78.9± 5.2 74 6.5 60.7± 4.7 C 186.3±36* C 91.3± 5.2 106.2±11
Alkalosis 192 244 362 200±22 181 204 153 252.6±36
a All values are the mean± SEM, expressed as a percentage of the control value.
b All mean percentages are significantly different from the control (P< .01), except as otherwise indicated: values marked *are significant
at P<.05, those marked+ are not significant.
C Experimental values too low to measure accurately, but significantly less than control.
than oxaloacetate; in the kidney, on the other hand, all the
intermediates were greatly increased above normal.
The large percentage increase in the concentration of
oxaloacetate in both liver and kidney, a phenomenon not
to my knowledge previously reported, deserves a brief
additional comment. Oxaloacetate is both the end product
of a series of oxidative reactions in the citric acid cycle and
a substrate for the citrate synthase reaction. If alkalosis
either enhanced the synthase reaction or, as suggested
above, inhibited the oxidative reactions coupled to the
citric acid cycle, a rise in pH would be expected to lower
rather than raise the concentration of oxaloacetate. The
data in Table 4 therefore suggest that alkalosis may facili-
tate the formation of oxaloacetate from pyruvate via the
carboxylase reaction, or inhibit the removal of oxaloacetate
from the citric acid cycle via the gluconeogenic pathway
and the PEPCK reaction.
Gluconeogenesis. Not much is known about the effects
of pH on the pyruvate carboxylase reaction in the kidney,
but it is known that liver pyruvate carboxylase is markedly
sensitive to pH and increases its activity in vitro as pH rises
[8, 54]. Although it has been suggested that this sensitivity
of the isolated enzyme to alkali may enhance hepatic
gluconeogenesis from lactate when there is hepatic intra-
cellular alkalosis [55], the significance of this property of the
carboxylase is difficult to assess. The increased hepatic
tissue levels of lactate shown in Table 4, as well as the
results of studies with tissue slices and intact preparations
[33, 56, 57], would suggest that an acute rise in pH inhibits,
or even reverses, the normal hepatic utilization of lactate.
Such studies do not indicate whether this effect on lactate
utilization is due to a block in the gluconeogenic pathway
or to impairment of oxidative reactions. In a perfused rat
liver preparation, with lactate as substrate, there was no
change in glucose production with variation in medium pH
from 7.1 to 7.7; at higher pH's gluconeogenesis was pro-
gressively reduced, but at pH 7.0 there was also a reduction
in glucose production [58]. Thus, it is not yet clear how
acute changes in pH affect the pathway in liver leading from
pyruvate to glucose and no satisfactory explanation can be
offered at this time for the changes in hepatic oxaloacetate
shown in Table 4.
The control of gluconeogenesis in the liver and its modi-
fication by pH clearly still awaits definitive study, but there
is substantial evidence that several of the physiological
factors known to influence hepatic gluconeogenesis are
relatively unaffected by acid-base status, whereas renal
glucose production is markedly affected by pH [59]. There
is good evidence that in kidney cortex, if not in liver, the
utilization of oxaloacetate and other citric acid cycle inter-
mediates via the PEPCK pathway is inhibited in alkalosis
and enhanced in acidosis. Several studies have shown that
acidosis in vitro or in vivo increases gluconeogenesis in
aerobic kidney slices from the rat and the dog, using sub-
strates such as glutamine, -ketoglutarate, oxaloacetate,
pyruvate or lactate (e.g., [60—63]). On the other hand,
measurements of net renal output of glucose in intact dogs
have yielded inconsistent results, some demonstrating in-
creased gluconeogenesis in acidosis [64] and others show-
ing no consistent effect [65, 66]. Analyses of renal tissue in
chronic acidosis have shown an increase in the concentra-
tion of phospho-enol-pyruvate [50, 52, 53] and enhanced
activity of PEPCK [53, 67, 68], and these findings, taken
together with the reduction in the concentrations of citric
acid cycle intermediates, supported the suggestion that
increased PEPCK activity was the controlling factor in the
increased gluconeogenesis with acidosis [50, 67]. However,
the renal tissue concentration of phospho-enol-pyruvate
does not change significantly in the first few fours after
the development of acidosis [51, 53], nor does PEPCK
activity increase [53], despite the fact that glucose produc-
tion in vitro has already increased and the concentrations
of citric acid cycle intermediates have already been reduced.
Thus, although induction of PEPCK may well be important
in maintaining the reduced renal tissue levels of citric acid
cycle intermediates in chronic acidosis, other mechnisms
must be sought to explain the initial acute response to
change in pH. Chronic acidosis has no, or relatively little,
effect on PEPCK activity in liver [67, 68]. Although it is
tempting to conclude that this explains why pH appears to
have less effect on gluconeogenesis in the liver than it has
in the kidney, final judgment must be withheld pending
further information about the mechanisms normally con-
trolling gluconeogenesis and the citric acid cycle.
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Before concluding this discussion of the effects of pH on
the citric acid cycle and the gluconeogenic pathway, some
brief mention must be made of the possible relation of these
phenomena to renal ammoniagenesis. When it was first
discovered that acidosis stimulted the production of glucose
from glutamine, glutamate and c-ketoglutarate in renal
cortical slices, it was suggested that the enhancement of
ammonia production in acidosis might be secondary to
activation of the gluconeogenic pathway [60]. This intri-
guing hypothesis has stimulated a great many studies of the
relationship between gluconeogenesis and ammoniagenesis
and has initiated a lively but still unresolved debate. This
subject is beyond the scope of this review, but is discussed
in another paper of the present symposium.
Summary. To summarize this section, therefore, we can
say that there is evidence for important effects of pH on the
metabolic pathways in the kidney that lead from pyruvate
into the citric acid cycle and the gluconeogenic sequence.
Alkalosis appears to produce a relative block in the oxida-
tion of the citric acid intermediates and also seems to inhibit
the flow of substrates from pyruvate and the citric acid
cycle into the gluconeogenic pathway. Acidosis has the
opposite effect. The sites and mechanisms of these effects
are not yet clearly defined, but the available data suggest
that an interaction of H+ with one or more of the cyto-
chromes may affect their oxidation-reduction behavior and
thereby change the redox state of the mitochondria. The
influence of sustained acidosis on the gluconeogenic path-
way may be in part mediated through enhancement or
induction of PEPCK, but the acute effects of pH change
are probably exerted at additional as yet unidentified points
beyond phospho-enol-pyruvate. The extent to which these
effects occur in tissues other than kidney cortex is not
definitely known, but liver shares these phenomena to some
degree. The effects on redox state and citric acid cycle
oxidations occur in liver and probably brain, muscle and
most other tissues capable of oxidative phosphorylations.
In the renal cortex at least, and perhaps in other tissues,
these effects on oxidation and gluconeogenesis probably
contribute to the maintenance of increased pyruvate levels
when glycolysis is stimulated by a rise in pH.
pH, lactic dehydrogenase equilibrium and the L/P ratio
The reversible lactic dehydrogenase (LDH) reaction,
pyruvate + NADH + H lactate+ NAD,
is the last step in the glycolytic sequence (Table 2). Hence,
the net rate of flux through this reaction determines the net
rate of formation of lactate. Even though the flux rate may
be rapid, the activity of the enzyme is sufficient to assure
that the concentrations of metabolites on both sides of the
reaction in the steady state are close to thermodynamic
equilibrium [69].
This means that at any given concentration of pyruvate
(P) in the cytoplasm, the concentration of lactate (L) in the
cytoplasm will be given by the expression:
(L)=(Ka) (IkDT-I) (Hf) (P) (1)
where Ka=the equilibrium constant for LDH, NADH/
NAD =the ratio of the concentration of free, reduced
nicotinamide adenine dinucleotide in the cytoplasm to that
of the free, oxidized from of the dimicleotide, and (H+)=
the hydrogen ion activity at the site of the LDH reaction.
According to this equation, at any given concentration
of (P), the concentration of (L) will be determined by the
redox state of the NAD-NADH couple, and the acidity of
the cell interior. Thus, the ratio of lactate to pyruvate in
cytoplasm should be higher when the dinucleotide couple
is relatively reduced and when the cytoplasm becomes more
acidified; the ratio should be lower when the cytoplasmic
pyridine dinucleotide couple is oxidized and when the
cytoplasm becomes more alkalotic.
Inasmuch as the concentrations of lactate and pyruvate
are probably uniform throughout the cell, while the NAD
and NADH which is in equilibrium with the LDH reaction
is confined to the cytoplasm [71], measurements of total
tissue (L)/(P) can be used to give some idea of the NADH/
NAD ratio in cytoplasm, provided that changes in (H+)
are taken into account. The problem in attempting to
calculate NADH/NAD by this method is that cytoplasmic
(H+) is not known with any precision. However, the data
in Table 4 do permit certain qualitative conclusions about
the effects of pH on the redox state in the cytoplasm. Table 4
shows that in acute alkalosis there was a much larger in-
crease in renal lactate concentration than in renal pyruvate.
In liver the difference was smaller but still lactate increased
relatively more than pyruvate. The L/P ratio therefore
increased 65% above normal in kidney, but only 15 % in
liver. The cytoplasmic (H+) was not determined, but can be
assumed to have decreased at least to some degree because
extracellular alkalosis was very severe (pH 7.6 to 7.8). An
increase in (L)/(P) ratio despite a reduction in (H+) must
mean that there is a significant increase in cytoplasmic
NADH/NAD ratio in alkalosis. This calculation therefore
tends to support the data obtained by direct analysis of
whole tissue for NADH and NAD, but it says nothing
about the redox state of the pyridine nucleotide couples in
the mitochondria. To estimate the changes in mitochondrial
NADH/NAD produced by alkalosis, one would need to use
an intramitochondrial equilibrium such as the f3-hydroxy-
butyrate dehydrogenase, or the glutamate dehydrogenase
systems [70, 71]. Application of this approach to organs
and tissues exposed to varying acid-base conditions has not
yet been reported.
A recent study of the effects of pH on lactate and pyruvate
production by liver slices [33] suggests that the cytoplasmic
NADH/NAD ratio probably increased when the pH of the
medium was increased. However, the medium, rather than
the tissue, was analyzed for lactate and pyruvate, and the
(L)/(P) ratios of the tissue and the medium may not be the
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same. A similar problem arises in the interpretation of
another study which used brain slices [72]. In these experi-
ments the (L)/(P) ratio did not seem to bear any relation to
pH of the medium, but tissue plus medium was analyzed.
There have been other experiments in which (L)/(P) ratios
were measured in brain tissue after acute respiratory
alkalosis had been produced in vivo by hyperventilation
[72—74]. Studies of this sort are complicated by the fact
that hypocapnia reduces cerebral blood flow and hence
may cause tissue anoxia. Increases in tissue (L)/(P) ratio
under these circumstances could represent the effects of
either decreased oxygen delivery to the brain or a defect
in cellular oxidative processes, and the data do not allow
separate assessment of these two factors. There have also
been many studies of the effect of respiratory or metabolic
disturbances in acid-base balance on the lactate and pyruvate
concentration of blood or spinal fluid. Some experiments
have shown only a slight rise in blood lactate and pyruvate
with respiratory or metabolic alkalosis, and slight or no
significant change in (L)/(P) ratio (e.g., [5, 76—78]), but
others have shown more substantial rises in blood levels
and a significant increase in (L)/(P) ratio of blood or spinal
fluid (e.g., [56, 79, 80]). In these latter experiments, inter-
mittent positive pressure ventilation probably reduced car-
diac output, thereby adding the stimulus of hypoxia to that
of alkalosis. Regardless of the circulatory effects, however,
experiments of this general type are difficult to interpret
because of the complexities of dealing with blood levels
rather than tissue levels of lactate and pyruvate. The con-
centrations of lactate and pyruvate in the blood are the net
result of the production and consumption of these metabo-
lites by different organs and tissues, some of which prob-
ably respond to alkalosis in different ways. There is little
reason to believe that the (L)/(P) ratio of blood would bear
a constant relationship to the (L)/(P) ratio in any one
particular tissue or in tissues as a whole.
The effect of pH on the (L)/(P) ratio of red blood cells
is an interesting phenomenon that deserves a brief separate
comment. The red cell of course does not have mitochondria
and can be regarded as a homogeneous, single-compartment
system in which glycolysis is the only means of energy
production. Lacking mitochondrial oxidative reactions, the
red cell might not be expected to show any effect of pH on
the redox state of the NAD couple. In fact, however, a
rise in the pH of the incubating medium from 7.0 to 8.0
results in a several-fold rise in the (L)/(P) ratio [10, 81].
Since intracellular (H+) must decrease, it is apparent from
Eq. (1) that NADI-1/NAD must increase considerably as pH
rises.
The explanation for this effect of pH on the redox state
of the NAD couple obviously cannot involve any block
in the oxidation of NADH in mitochondria. Instead, it
may be suggested that the mechanism depends on a pH-
induced shift in the position of the glyceraldehyde-3-P
dehydrogenase equilibrium [82]. As shown in Table 2, the
dehydrogenase reaction is one of the four reactions in the
glycolytic sequence that is far from its thermodynamic
equilibrium in vivo and is therefore considered to be one
of the potential rate-controlling steps [8]. The overall reac-
tion, which can be written:
Glyc-3-P +P +NAD± 1,3 PGA + NADH +1-1+
is the only Embden-Meyerhof reaction, other than LDH,
that is coupled to NAD. It generates the NADH required
for the LDH reaction; conversely, the LDH reaction gener-
ates the NAD required for the dehydrogenase step. There-
fore, if a rise in pH were to enhance the forward dehydro-
genase reaction, moving its steady state position closer to
thermodynamic equilibrium, this would tend to increase
the NADH/NAD ratio and thereby increase the (L)/(P)
ratio. In support of this mechanism is the fact, mentioned
earlier, that crossover studies (Fig. 1) indicate the dehydro-
genase step to be another point of control by pH, in addition
to PFK. The crossover experiments in Fig. I were carried
out on intact leukocytes—cells which contain mitochondria
and are capable of oxidative phosphorylation. If the pro-
posed mechanism does indeed operate in red cells, there
is no reason why it could not also be a factor in other cells
as well. It is quite possible that alkalosis exerts separate and
independent effects on the redox state of the pyridine
nucleotides—in mitochondria through a partial block of the
electron carrier system, and in cytoplasm through the effect
on the dehydrogenase equilibrium. Changes in the (L)/(P)
ratio would be expected to reflect only the cytoplasmic
effects.
The response of the glycolytic system in the red cell to a
rise in pH is unique in another respect. Unlike most other
tissues, the red cell does not increase its pyruvate concen-
tration as the rate of glycolysis is enhanced [10, 81]. The
large increase in the (L)/(P) ratio discussed above is evi-
dently one explanation. Another explanation may reside in
the fact that the mature red cell has no pathway for pyru-
vate utilization other than through the LDH reaction,
whereas in most other tissues pyruvate is rapidly utilized in
the citric acid cycle, or in the gluconeogenic pathway.
We have seen that in the kidney cortex alkalosis inhibits
these routes of disposal and thus tends to keep the tissue
concentration of pyruvate elevated, even though it is also
being converted to lactate at an increased rate.
pH and the hexose monophosphate shunt
The cytoplasmic hexose monophosphate (HMP) shunt
is apparently activated by chronic acidosis in vitro in the
kidney cortex [83] and by acute reduction of pH in red
blood cells incubated in vitro [81]. In the rat, mouse and
guinea pig kidney the activity of the HMP shunt dehydro-
genases (glucose-6-P dehydrogenase and 6-phosphogluco-
nate dehydrogenase) is increased by acidosis [83]. The shunt
dehydrogenases are dependent upon the availability of
NADP and require a low NADPH/NADP ratio to be
maximally active. Inasmuch as alkalosis increases the cyto-
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plasmic NADH/NAD ratio, it is not surprising that it
should also lower the redox state of the NADP couple
and inhibit dehydrogenase activity. This is purely specula-
tive, however, and it must be admitted that at present
neither the mechanism nor the physiological significance
of the pH effect on HMP shunt activity is clearly under-
stood [84].
One consequence of this effect seems clear enough: in
alkalosis, when glycolysis is optimal, deviation of glucose-
6-P into the shunt pathway is minimal; and in acidosis,
when PFK is inhibited, a relatively large part of the remain-
ing flux from glucose to pyruvate is accounted for by
substrate which has bypassed PEK via the shunt pathway
[81]. The shunt pathway is important in the generation of
NADPH that is necessary for the synthesis of fatty acids
and for the function of various hydrolases; it also serves as
a source of ribose. It remains to he seen whether these
special roles of the HMP shunt pathway have any special
significance in acidosis [84].
Hypoxia and alkalosis: A comparison of their metabolic
effects
Acute hypoxia and alkalosis are both forms of physio-
logical stress that seem to have extensive effects on meta-
bolic processes. It is instructive to compare them in terms
of the pathways and biochemical parameters we have been
discussing.
Glycolysis, Both are potent activators of PFK and
glycolytic pathway in all tissues studied but, as discussed
above, their mechanisms of action are different. Hypoxia
acts by changing the tissue concentrations of citrate, phos-
phate and the adenine nucleotides, which are regulators of
PFK. Alkalosis acts directly on the enzyme protein.3
Citric acid cycle. Alkalosis increases the tissue concen-
trations of all the measurable citric acid cycle intermediates
(Table 4): this results from a partial block in their oxidation
via the electron transport system, and from inhibition of
the utilization of oxaloacetate via the gluconeogenic path-
way (in renal cortex, at least). Hypoxia, on the other hand,
blocks the oxidative decarboxylation of pyruvate and hence
reduces the entry of substrate into the cycle. Therefore,
citrate is reduced while pyruvate accumulates; oxaloacetate
and -ketog1utarate are also reduced (29).
Oxidations. There is suggestive evidence that alkalosis
partially blocks mitochondrial oxidations; the redox state
of the cytoplasmic pyridine dinucleotide is also reduced.
However, in the steady state the rate of oxidative phos-
phorylation is apparently normal because ATP levels and
In the red blood cell, where there is no endogenous citrate and
no dependence on oxygen for ATP synthesis, glycolysis is
still stimulated by anoxia [851. The mechanism appears to
depend upon a small increase in intracellular pH due to the
deoxygenation of hemoglobin [85, 861. There is also an in-
crease in the binding of 2,3-diphosphoglycerate to hemoglobin,
which indirectly acts to facilitate pyruvic kinase [87].
oxygen consumption are generally unaffected. Hypoxia, on
the other hand, leads to abrupt and drastic reduction in
oxidative phosphorylations, a reduction in the redox state
of all the pyridine nucleotides and a progressive decline in
tissue ATP and other high energy phosphate compounds
such as creatine phosphate [26, 29, 88—91].
Gluconeogenesis. Alkalosis inhibits the utilization of
oxaloacetate, c-ketoglutarate, pyruvate and lactate in the
gluconeogenic pathway through PEPCK in the kidney
cortex and possibly in other tissues. Hypoxia also inhibits
gluconeogenesis by mechanisms that probably involve the
reduction in high energy phosphate compunds upon which
key gluconeogenic reactions are dependent.
Summary and conclusions
It is apparent from this brief review that pH exerts
important influences at many points in the pathways leading
to the utilization and production of glucose and high-
energy compounds. Most of these effects, though apparently
diverse, can probably be ultimately explained through the
influence of protonation and deprotonation upon the
activity of rate-controlling enzymes. There is a remarkable
analogy between the effects of alkalosis and those of
hypoxia. Although their mechanisms of action are often
distinct, these two physiological stresses appear to act in
concert to enhance glycolysis, and to inhibit gluconeogene-
sis, HMP shunt activity and citric acid cycle oxidations.
Conversely, the effects of hypoxia on all these processes
tend to be opposed by the effects of acidosis.
It is tempting, but probably fruitless at this point, to
speculate on the biological significance of this interplay
between the oxidative state and acid-base balance. However,
what should be apparent from this review is that disturb-
ances in the pH of body fluids may have profound effects
on the biochemical processes responsible for energy pro-
duction and utilization. Future explorations of the clinical
and physiological phenomena of acid-base disorders will
undoubtedly be increasingly concerned with this aspect of
the problem.
Reprint requests to Dr. A. S. Re/man, Department of Medicine,
University of Pennsylvania School of Medicine, 3400 Spruce
Street, Philadelphia, Pennsylvania 19104, U.S.A.
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